Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer

Clinical trial NCT01020305 · TERMINATED

Trial details

NCT number: NCT01020305
Sponsor: Sandy Srinivas
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Prostatic Neoplasms Castrate-resistant Prostate Cancer (CRPC)Androgen-insensitive Prostate Cancer Hormone-refractory Prostate Cancer Metastatic Disease

Start date: 2009-10-01
Primary completion: 2012-04-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.